INSERM, Paris Cardiovascular Research Centre, University Paris Descartes, Sorbonne Paris Cité, France
Institute of Epidemiology and Social Medicine, University of Münster, Germany.
Eur J Prev Cardiol. 2015 Sep;22(9):1212-9. doi: 10.1177/2047487314564728. Epub 2014 Dec 16.
Readiness for smoking cessation is an important predictor of quit attempts and cessation success. We aimed to investigate the prevalence and correlates of readiness for smoking cessation in coronary heart disease (CHD) patients.
The EUROpean Action on Secondary and Primary Prevention by Intervention to Reduce Events III (EUROASPIRE III) survey is a cross-sectional study conducted in 2006-2007 among CHD patients <80 years of age from 22 European regions.
Patients were interviewed on average 15 months after hospital admission for an acute coronary event or procedure. Readiness for smoking cessation was assessed using the smoking stages of change (SSC) short form questionnaire. Breath carbon monoxide was measured to validate self-reported non-smoking.
Among 2585 patients who were smoking prior to hospital admission, 25.6%, 16.8%, 8.1%, 5.6% and 44.0% were in the precontemplation (no intention to quit), contemplation (thinking of quitting), preparation (planning to quit), action (having quit within six months) and maintenance (having quit more than six months ago) stages, respectively. Significant multivariable correlates of advancement in SSC showed positive associations of older age and attended cardiac rehabilitation and negative associations of severe depressive symptoms, longer smoking duration and environmental tobacco smoke (ETS) exposure.
One-quarter of CHD patients across Europe who were smoking prior to hospitalisation have no intention to quit, and an additional quarter is thinking of quitting or planning to quit. Patients who are younger, do not attend cardiac rehabilitation, have severe depressive symptoms, have been smoking for longer periods of time and are exposed to ETS may need to be specifically targeted in cessation interventions.
戒烟准备度是戒烟尝试和成功的重要预测指标。我们旨在调查冠心病（CHD）患者戒烟准备度的流行情况及其相关因素。
EUROpean Action on Secondary and Primary Prevention by Intervention to Reduce Events III（EUROASPIRE III）调查是一项横断面研究，于 2006 年至 2007 年在 22 个欧洲地区进行，对象为年龄<80 岁的 CHD 患者。
患者在急性冠脉事件或经皮冠状动脉介入治疗后平均 15 个月接受访谈。使用吸烟阶段变化（SSC）短问卷评估戒烟准备度。测量呼出气一氧化碳以验证自我报告的非吸烟情况。
在 2585 名入院前吸烟的患者中，分别有 25.6%、16.8%、8.1%、5.6%和 44.0%处于未考虑（无戒烟意向）、考虑（考虑戒烟）、准备（计划戒烟）、行动（戒烟在六个月内）和维持（戒烟超过六个月）阶段。SSC 进展的多变量显著相关因素表明，年龄较大、参加心脏康复与积极进展呈正相关，而严重抑郁症状、吸烟时间较长和接触环境烟草烟雾（ETS）与消极进展呈负相关。
在欧洲，入院前吸烟的 CHD 患者中有四分之一没有戒烟意向，另有四分之一正在考虑或计划戒烟。年龄较小、不参加心脏康复、有严重抑郁症状、吸烟时间较长和接触 ETS 的患者可能需要在戒烟干预中特别针对这些患者。
